PL378222A1 - Tienopirymidynodiony i ich zastosowanie w modulacji choroby autoimmunologicznej - Google Patents

Tienopirymidynodiony i ich zastosowanie w modulacji choroby autoimmunologicznej

Info

Publication number
PL378222A1
PL378222A1 PL378222A PL37822204A PL378222A1 PL 378222 A1 PL378222 A1 PL 378222A1 PL 378222 A PL378222 A PL 378222A PL 37822204 A PL37822204 A PL 37822204A PL 378222 A1 PL378222 A1 PL 378222A1
Authority
PL
Poland
Prior art keywords
thienopyrimidinediones
sup
modulation
autoimmune disease
compounds
Prior art date
Application number
PL378222A
Other languages
English (en)
Other versions
PL214682B1 (pl
Inventor
Simon David Guile
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of PL378222A1 publication Critical patent/PL378222A1/pl
Publication of PL214682B1 publication Critical patent/PL214682B1/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Transplantation (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
PL378222A 2003-01-17 2004-01-15 Tienopirymidynodiony, sposób ich wytwarzania oraz zawierajacy je srodek farmaceutyczny PL214682B1 (pl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE0300119A SE0300119D0 (sv) 2003-01-17 2003-01-17 Novel compounds

Publications (2)

Publication Number Publication Date
PL378222A1 true PL378222A1 (pl) 2006-03-20
PL214682B1 PL214682B1 (pl) 2013-09-30

Family

ID=20290154

Family Applications (1)

Application Number Title Priority Date Filing Date
PL378222A PL214682B1 (pl) 2003-01-17 2004-01-15 Tienopirymidynodiony, sposób ich wytwarzania oraz zawierajacy je srodek farmaceutyczny

Country Status (23)

Country Link
US (2) US7384951B2 (pl)
EP (1) EP1587812B1 (pl)
JP (1) JP4519121B2 (pl)
KR (2) KR101107486B1 (pl)
CN (1) CN100334093C (pl)
AT (1) ATE335748T1 (pl)
AU (1) AU2004206012B2 (pl)
BR (1) BRPI0406801B8 (pl)
CA (1) CA2512441C (pl)
DE (1) DE602004001857T2 (pl)
EG (1) EG25613A (pl)
ES (1) ES2270337T3 (pl)
IL (1) IL169370A (pl)
IS (1) IS2376B (pl)
MX (1) MXPA05007496A (pl)
NO (1) NO333702B1 (pl)
NZ (1) NZ541217A (pl)
PL (1) PL214682B1 (pl)
RU (1) RU2331647C2 (pl)
SE (1) SE0300119D0 (pl)
UA (1) UA81788C2 (pl)
WO (1) WO2004065394A1 (pl)
ZA (1) ZA200505364B (pl)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0117583D0 (en) * 2001-07-19 2001-09-12 Astrazeneca Ab Novel compounds
GB0118479D0 (en) * 2001-07-28 2001-09-19 Astrazeneca Ab Novel compounds
SE0300120D0 (sv) 2003-01-17 2003-01-17 Astrazeneca Ab Novel compounds
WO2004065395A1 (en) * 2003-01-17 2004-08-05 Astrazeneca Ab Thienopyridazinones and their use in modulation of autoimmune disease
PL1696920T3 (pl) 2003-12-19 2015-03-31 Plexxikon Inc Związki i sposoby opracowywania modulatorów Ret
US7498342B2 (en) 2004-06-17 2009-03-03 Plexxikon, Inc. Compounds modulating c-kit activity
CA2608733A1 (en) 2005-05-17 2007-02-01 Plexxikon, Inc. Pyrrol (2,3-b) pyridine derivatives protein kinase inhibitors
DK2395004T3 (en) 2005-06-22 2016-03-21 Plexxikon Inc Pyrrolo [2,3-b] pyridine derivatives as protein kinase inhibitors
WO2008063888A2 (en) 2006-11-22 2008-05-29 Plexxikon, Inc. Compounds modulating c-fms and/or c-kit activity and uses therefor
WO2008079909A1 (en) 2006-12-21 2008-07-03 Plexxikon, Inc. Pyrrolo [2,3-b] pyridines as kinase modulators
WO2008080015A2 (en) 2006-12-21 2008-07-03 Plexxikon, Inc. Compounds and methods for kinase modulation, and indications therefor
PE20081581A1 (es) 2006-12-21 2008-11-12 Plexxikon Inc COMPUESTOS PIRROLO[2,3-b]PIRIDINAS COMO MODULADORES DE QUINASA
GB0713479D0 (en) * 2007-07-11 2007-08-22 Syngenta Participations Ag Substituted aromatic heterocyclic compounds as fungicides
US20100190777A1 (en) 2007-07-17 2010-07-29 Plexxikon Inc. Compounds and methods for kinase modulation, and indications therefor
WO2010089580A1 (en) 2009-02-06 2010-08-12 Astrazeneca Ab Use of a mct1 inhibitor in the treatment of cancers expressing mct1 over mct4
SG174398A1 (en) * 2009-03-23 2011-10-28 Glenmark Pharmaceuticals Sa Furopyrimidinedione derivatives as trpa1 modulators
BRPI1009372A2 (pt) * 2009-03-23 2016-05-31 Glenmark Pharmaceuticals Sa compostos, composição farmacêutica e respectivos usos
HUE027598T2 (en) 2009-04-03 2016-10-28 Hoffmann La Roche Propane-1-sulfonic acid {3- [5- (4-chlorophenyl) -1H-pyrrolo [2,3-B] pyridine-3-carbonyl] -2,4-difluorophenyl} amide compositions and their uses
US8329724B2 (en) 2009-08-03 2012-12-11 Hoffmann-La Roche Inc. Process for the manufacture of pharmaceutically active compounds
ES2633317T3 (es) 2009-11-06 2017-09-20 Plexxikon, Inc. Compuestos y métodos para la modulación de quinasas, e indicaciones para ello
MA34948B1 (fr) 2011-02-07 2014-03-01 Plexxikon Inc Composes et procedes de modulation de kinase, et leurs indications
TWI558702B (zh) 2011-02-21 2016-11-21 普雷辛肯公司 醫藥活性物質的固態形式
EP2804852A2 (en) 2012-01-20 2014-11-26 Regents Of The University Of Minnesota Therapeutic compounds
US10085987B2 (en) 2012-01-27 2018-10-02 Thomas Jefferson University MCT protein inhibitor-related prognostic and therapeutic methods
US9150570B2 (en) 2012-05-31 2015-10-06 Plexxikon Inc. Synthesis of heterocyclic compounds
EP2986290A4 (en) 2013-04-19 2017-01-04 Thomas Jefferson University Caveolin-1 related methods for treating glioblastoma with temozolomide
NZ718576A (en) * 2013-10-21 2019-11-29 Genosco Substituted pyrimidine compounds and their use as syk inhibitors
JP6725519B2 (ja) * 2015-01-22 2020-07-22 ザ スクリプス リサーチ インスティテュート 複素環式のモノカルボン酸トランスポータ阻害薬
UY36586A (es) * 2015-03-26 2016-10-31 Bayer Pharma AG Heterociclilmetiltienouracilos y uso de los mismos
KR101712836B1 (ko) * 2016-03-17 2017-03-22 주식회사 골프존 가상 골프 시뮬레이션 장치, 가상 골프를 위한 영상 구현 방법 및 이를 기록한 컴퓨팅 장치에 의해 판독 가능한 기록 매체
KR101712838B1 (ko) * 2016-03-17 2017-03-07 주식회사 골프존 가상 골프 시뮬레이션 장치, 가상 골프를 위한 영상 구현 방법 및 이를 기록한 컴퓨팅 장치에 의해 판독 가능한 기록 매체
KR101730536B1 (ko) * 2016-03-17 2017-05-02 주식회사 골프존 스크린 골프 시스템에서 구현되는 컨텐츠 전송 서비스 방법, 컨텐츠 전송 서비스를 위한 모바일 단말기의 제어방법 및 이를 기록한 컴퓨팅 장치에 의해 판독 가능한 기록매체
TWI823932B (zh) * 2018-05-11 2023-12-01 中國大陸商迪哲（江蘇）醫藥有限公司 三唑并嘧啶化合物及其在治療癌症中之用途
CN119080799B (zh) * 2024-09-27 2025-12-05 山东大学 一种n-羟基噻吩并嘧啶二酮类衍生物及其制备方法与应用

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US738495A (en) * 1902-12-26 1903-09-08 William E Sherwood Thill-coupling.
SE9702001D0 (sv) * 1997-05-28 1997-05-28 Astra Pharma Prod Novel compounds
US6469014B1 (en) * 1997-05-28 2002-10-22 Astrazeneca Ab Thieno[2,3-d] pyrimidinediones, their preparation and use in therapy
SK8402000A3 (en) 1997-12-05 2001-03-12 Astrazeneca Uk Ltd Novel compounds
US6232320B1 (en) * 1998-06-04 2001-05-15 Abbott Laboratories Cell adhesion-inhibiting antiinflammatory compounds
CA2339664A1 (en) * 1998-08-28 2000-03-09 Astrazeneca Ab Thieno{2,3,-d}pyrimidinedione derivatives and their use as immunosuppressants
ATE272642T1 (de) * 2000-05-04 2004-08-15 Astrazeneca Ab Thieno(2,3-d)pyrimidindione und ihre verwendung als pharmazeutische mittel
GB0117583D0 (en) * 2001-07-19 2001-09-12 Astrazeneca Ab Novel compounds
GB0118479D0 (en) * 2001-07-28 2001-09-19 Astrazeneca Ab Novel compounds
WO2004065395A1 (en) 2003-01-17 2004-08-05 Astrazeneca Ab Thienopyridazinones and their use in modulation of autoimmune disease
SE0300120D0 (sv) * 2003-01-17 2003-01-17 Astrazeneca Ab Novel compounds

Also Published As

Publication number Publication date
BRPI0406801B8 (pt) 2021-05-25
HK1081959A1 (en) 2006-05-26
AU2004206012A1 (en) 2004-08-05
AU2004206012B2 (en) 2007-06-14
BRPI0406801A (pt) 2006-01-17
SE0300119D0 (sv) 2003-01-17
UA81788C2 (uk) 2008-02-11
JP4519121B2 (ja) 2010-08-04
DE602004001857D1 (de) 2006-09-21
JP2006516974A (ja) 2006-07-13
US7384951B2 (en) 2008-06-10
CA2512441C (en) 2012-01-03
RU2005121494A (ru) 2006-02-10
CN1761672A (zh) 2006-04-19
NO333702B1 (no) 2013-08-26
NZ541217A (en) 2008-05-30
ATE335748T1 (de) 2006-09-15
RU2331647C2 (ru) 2008-08-20
BRPI0406801B1 (pt) 2018-04-03
US20060052400A1 (en) 2006-03-09
NO20053826D0 (no) 2005-08-15
WO2004065394A1 (en) 2004-08-05
CA2512441A1 (en) 2004-08-05
ZA200505364B (en) 2006-09-27
KR20050092760A (ko) 2005-09-22
MXPA05007496A (es) 2005-09-21
KR20110125256A (ko) 2011-11-18
EP1587812B1 (en) 2006-08-09
EP1587812A1 (en) 2005-10-26
NO20053826L (no) 2005-10-17
KR101107486B1 (ko) 2012-01-19
IL169370A (en) 2011-05-31
IS2376B (is) 2008-07-15
EG25613A (en) 2012-03-22
DE602004001857T2 (de) 2007-05-24
PL214682B1 (pl) 2013-09-30
IL169370A0 (en) 2007-07-04
ES2270337T3 (es) 2007-04-01
US20080214579A1 (en) 2008-09-04
CN100334093C (zh) 2007-08-29
IS7965A (is) 2005-07-29

Similar Documents

Publication Publication Date Title
EG25613A (en) Thienopyrimidinediones and their use in the modulation of autoimmune disease
PL358281A1 (pl) Nowe związki
PL366198A1 (pl) Nowe związki
TW200508214A (en) Novel compounds
CA2481723A1 (en) 5ht2c receptor modulators
DE602004021472D1 (en) Pyrimiidinverbindungen
MXPA04004498A (es) Derivados de n-adamantilmetil e intermediarios como composiciones farmaceuticas y procesos para su preparacion.
DE60116761D1 (en) Adamantanderivate
IL164974A0 (en) Novel compounds and their use
AU2003228770A8 (en) Substituted pyrazolopyrimidines
IL173348A (en) Thienopyridine compounds, pharmaceuticals containing them and their use in the preparation of drugs
SE0300480D0 (sv) Novel compounds
TW200613243A (en) Novel compounds
SE0302139D0 (sv) Novel compounds
TW200604197A (en) New compounds
IL160171A0 (en) Depsipeptide derivatives, processes for the preparation thereof and pharmaceutical compositions containing the same
SE0402925D0 (sv) Novel Compounds
GB0104050D0 (en) Chemical compounds
GB0120461D0 (en) Novel compounds
SE0303280D0 (sv) Novel compounds
SE0401763D0 (sv) Compounds
MXPA02012426A (es) Compuestos nuevos.
DE60201074D1 (en) Pyrazolopyridinderivate
SE0202693D0 (sv) Compounds
SE0302755D0 (sv) Novel compounds

Legal Events

Date Code Title Description
RECP Rectifications of patent specification